logo
Syngulon - Bacteriocin-based technologies
logo
  • About us
    • Startup in the labs
    • Team
    • Scientific Advisory Board
    • CEO interview at BIO World Congress
  • Bacteriocins
    • History
    • Synthetic biology
    • Bacteriocins vs Antibiotics and Bacteriophages
    • Syngulon’s collection
  • Technologies
    • Technology presentations
    • Patents
    • Syngulon’s team publications
  • R&D
  • News
  • Join us!
  • Contact Us
newscast
Scientific Advisory Board

Syngulon, a synthetic biology startup, announced its Scientific Advisory Board (SAB) comprised of leading academic and industrial experts in microbiology with experience in both Europe and the USA. In 2016, the USPTO issued US Patent 9,333,227 to Syngulon for the use of bacteriocin/immunity in any bacteria, yeast or algae for controlled growth of microorganisms. The company anticipates that the SAB will address a variety of issues at the forefront of microbial fermentation technologies from the analysis of contaminants to the choice of bacteriocin/immunity.

Olivier

Leave a reply

Click here to cancel reply.

You must be logged in to post a comment.

Recent comments

    Tags

    Syngulon is member of

    Contact us

    Syngulon SA
    Rue du Bois Saint Jean 15/1
    B-4102 SERAING
    Belgium
    BCE / VAT: BE 0521.816.349

    Email: contact(at)syngulon.com

    © 2018 Syngulon
    logo